Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05545124
What this trial is testing

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Who this might be right for
Hepatocellular Carcinoma
Henan Cancer Hospital 32
Early research (Phase 1)UnknownNCT02399735
What this trial is testing

Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 18
Testing effectiveness (Phase 2)Study completedNCT00128596
What this trial is testing

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 25
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Post-approval studies (Phase 4)Not Yet RecruitingNCT06311916
What this trial is testing

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Who this might be right for
HCC
Chen Xiaoping 312
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Large-scale testing (Phase 3)Study completedNCT00012324
What this trial is testing

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Who this might be right for
Liver Cancer
Eximias Pharmaceutical
Post-approval studies (Phase 4)Active Not RecruitingNCT03024684
What this trial is testing

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

Who this might be right for
HepatoCellular Carcinoma
Chiayi Christian Hospital 240
Early research (Phase 1)UnknownNCT03966209
What this trial is testing

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

Who this might be right for
Hepatocellular CarcinomaLiver Transplantation
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Not applicableStudy completedNCT01963429
What this trial is testing

Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC

Who this might be right for
Recurrent Small Hepatocellular CarcinomaResidual Small Hepatocellular Carcinoma
National Cancer Center, Korea 144
Not applicableStudy completedNCT00817895
What this trial is testing

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Not applicableStudy completedNCT00834028
What this trial is testing

Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)UnknownNCT04888546
What this trial is testing

TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis

Who this might be right for
Patients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or Metastasi
Chinese Academy of Medical Sciences 20
Next Page